Navigation Links
Severe asymptomatic heart disease may accompany narrowing in leg arteries
Date:12/1/2009

CHICAGO Results of a randomized, controlled clinical trial presented today at the annual meeting of the Radiological Society of North America (RSNA) reveal that one in five patients with narrowing or blockage in arteries that supply blood to the legs and other parts of the body also have significant but silent coronary artery disease.

Peripheral arterial disease (PAD) occurs when plaque, a combination of fat, cholesterol and other substances, builds up in the arteries, limiting the flow of oxygen-rich blood throughout the body. PAD usually affects arteries that carry blood to the legs, causing poor circulation, discomfort and pain. More than eight million Americans have PAD, according to the American Heart Association.

According to the National Heart, Lung and Blood Institute, coronary artery disease is the most common type of heart disease and the leading cause of death in the U.S.

"PAD patients, including those experiencing no symptoms of heart disease, are known to be at high risk for cardiovascular events such as a heart attack or stroke," said Rozemarijn Vliegenthart Proenca, M.D., Ph.D., radiology resident at the University Medical Center Groningen in the Netherlands. "The purpose of our clinical trial was to investigate whether noninvasive imaging of the heart and subsequent treatment of PAD patients result in a decrease in cardiac events compared to standard care."

In the clinical trial, a total of 231 PAD patients from four participating hospitals in the Netherlands were divided into one of two groups: one in which 108 patients received standard careconsisting of lifestyle changes and medicationfor their condition, and a second group in which 115 patients underwent cardiac imaging of the heart in addition to standard care.

"With new, noninvasive cardiac imaging techniques, asymptomatic coronary atherosclerosis can be readily detected and treated," Dr. Vliegenthart Proenca said.

Among the 115 patients who received cardiac imaging, computed tomography (CT) revealed that 53, or 46 percent, had at least one significant narrowing of a coronary artery. Of those 53 patients, 22 had significant narrowing in the left main coronary artery or its equivalent, and were referred for treatment. Eight of those patients subsequently had bypass surgery, and three underwent coronary angiography with stent placement. The remaining patients were treated with medication.

Cardiac stress MRI was then performed on 76 patients. Cardiac stress MRI, in which a drug is infused into the patient's bloodstream to make the heart work harder, helps determine if the heart muscle is receiving adequate blood flow. Results of the cardiac stress MRI exams identified two additional patients with signs of coronary artery disease, one of whom underwent angiography and stent placement.

In total, 24 (21 percent) of the 115 patients who underwent imaging had evidence of asymptomatic but severe coronary artery disease that required additional treatment.

"In PAD patients experiencing no cardiac symptoms, we found a strikingly high rate of severe coronary artery disease," Dr. Vliegenthart Proenca said. "The results of our trial stress that PAD patients without a history of cardiac symptoms should undergo extensive cardiovascular risk factor management."


'/>"/>

Contact: Linda Brooks
lbrooks@rsna.org
630-590-7762
Radiological Society of North America
Source:Eurekalert

Related medicine news :

1. Scientists puzzled by severe allergic reaction to cancer drug in the middle Southern US
2. Surgery for severe obesity saves lives
3. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
4. Primary biliary cirrhosis more severe in African-American and Hispanic patients
5. South Texas Doctors Report More Severe Cases of Community Staph Super Bug Hospitalizing Children
6. Severe heart attack damage limited by hydrogen sulfide
7. Women with severe PMS perceive their sleep quality to be poor
8. First significant genetic finding in severe PMS, or PMDD
9. 10th Anniversary of Revolutionary Teaching Approach that Offers the Severely Disabled the Gift of Self-Expression - Through Painting
10. Severe heart defect likely caused by genetic factors
11. MS that runs in families appears more severe than non-familial MS
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2016)... (PRWEB) , ... May 04, 2016 , ... Over 40 ... convened in the state capitol for the annual “Hike to Harrisburg” advocacy day. ... and The Winter Group, PATS lobby Group. The goal for the day was ...
(Date:5/4/2016)... ... ... , a leading provider of barcode and RFID labels has acquired ... to continue to grow its label business, customer base and market share. , Netc ... print and label tape media on site and on an as needed basis. Many of ...
(Date:5/3/2016)... ... May 03, 2016 , ... ProIntro Glitch is a set of ... Film Studios’ titles allow users to add a terrifying opener to any video or ... lines and accents. To add greater contrast, all the user has to do is ...
(Date:5/3/2016)... ... May 03, 2016 , ... Sue Desmond-Hellmann, chief executive officer ... to stretch the limits of human possibility in her keynote address at Georgia State ... Georgia Dome. , Drawing on her rich experience as a scientist, physician and executive, ...
(Date:5/3/2016)... ... May 03, 2016 , ... Calvary Hospital recently hosted a reception to ... a 10-bed unit located at Mary, Manning Walsh Home (MMW) in Manhattan. , ... DGH for half an hour, once a week. The music brings a lot of ...
Breaking Medicine News(10 mins):
(Date:5/2/2016)... YORK , May 2, 2016 Kalorama ... EMR (Electronic Medical Records) market in a recent white ... sales, vendor switches, Increased physician usage, a growing market are ... were noted in Kalorama,s report EMR 2016: ... report marks Kalorama,s seventh complete study of the EMR ...
(Date:5/2/2016)... NEW YORK , May 2, 2016 /PRNewswire/ ... Series B financing of Graybug Vision, Inc. Graybug ... to developing therapies that may transform care for ... and glaucoma.  Graybug Vision,s technology was first developed ... out into a startup venture. ...
(Date:5/2/2016)... LAWRENCEVILLE, N.J. , May 2, 2016 /PRNewswire/ ... drug development company, today announced data from the ... dose escalating clinical trial (the OVATION Study) combining ... of care for the treatment of newly-diagnosed patients ... chemotherapy followed by interval debulking surgery.  In the ...
Breaking Medicine Technology: